Strategies for Improving Care

	2016 ADA Guideline Recommendations
Types of Diabetes Mellitus
Main Diabetes Page
Diabetes type I
Diabetes type II
Gestational Diabetes Mellitus
2016 ADA Standard of Medical Care Guideline Recommendations
Strategies for Improving Care
Classification and Diagnosis of Diabetes
Foundations of Care and Comprehensive Medical Evaluation Diabetes Self-Management, Education, and Support Nutritional Therapy
Prevention or Delay of Type II Diabetes
Glycemic Targets
Obesity Management for Treatment of Type II Diabetes
Approaches to Glycemic Treatment
Cardiovascular Disease and Risk Management Hypertension and Blood Pressure Control Lipid Management Antiplatelet Agents Coronary Heart Disease
Microvascular Complications and Foot Care Diabetic Kidney Disease Diabetic Retinopathy Diabetic Neuropathy Diabetic Footcare
Older Adults with Diabetes
Children and Adolescents with Diabetes Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes Microvascular Complications in Children and Adolescents with Diabetes
Management of Diabetes in Pregnancy
Diabetes Care in the Hospital Setting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]

2016 ADA Standards of Medical Care in Diabetes Guidelines

"1. A patient-centered communication style that incorporates patient preferences, assesses literacy and numeracy, and addresses cultural barriers to care should be used. (Level of Evidence: B)"
"2. Treatment decisions should be timely and based on evidence-based guidelines that are tailored to individual patient preferences, prognoses, and co- morbidities. (Level of Evidence: B)"
"3. Care should be aligned with components of the Chronic Care Model to ensure productive interactions between a prepared proactive practice team and an informed activated patient. (Level of Evidence: A)"
"4. When feasible, care systems should support team-based care, community involvement, patient registries, and decision support tools to meet patient needs. (Level of Evidence: B)"

"1. Providers should evaluate hyperglycemia and hypoglycemia in the context of food insecurity and propose solutions accordingly. (Level of Evidence: A)"
"2. Providers should recognize that homelessness, poor literacy, and poor numeracy often occur with food insecurity, and appropriate resources should be made avail- able for patients with diabetes. (Level of Evidence: A)"

"1. Intensive glucose control is not ad- vised for the improvement of poor cognitive function in hyperglycemic individuals with type 2 diabetes. (Level of Evidence: B)"
"2. In individuals with poor cognitive function or severe hypoglycemia, glycemic therapy should be tailored to avoid significant hypoglycemia. (Level of Evidence: C)"
"3. In individuals with diabetes at high cardiovascular risk, the cardiovascular benefits of statin therapy outweigh the risk of cognitive dysfunction. (Level of Evidence: A)"
"4. If a second-generation antipsychotic medication is prescribed, changes in weight, glycemic control, and cho- lesterol levels should be carefully monitored and the treatment regi- men should be reassessed. (Level of Evidence: C)"

"1. Patients with HIV should be screened for diabetes and prediabetes with a fasting glucose level before starting antiretroviral therapy and 3 months after starting or changing it. If initial screening results are normal, check- ing fasting glucose each year is ad- vised. If prediabetes is detected, continue to measure levels every 3–6 months to monitor for pro- gression to diabetes. (Level of Evidence: E)"